BioXcel Therapeutics (BTAI) Reports Q4 Loss of $0.87/sh

Go back to BioXcel Therapeutics (BTAI) Reports Q4 Loss of $0.87/sh
(NASDAQ: BTAI) Delayed: 1.19 +0.06 (5.31%)
Previous Close $1.13    52 Week High
Open $1.11    52 Week Low
Day High $1.24    P/E N/A 
Day Low $1.02    EPS
Volume 2,030,939